Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.ORCID iD: 0000-0002-1864-1258
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.ORCID iD: 0000-0002-0915-5303
Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Natl Bioinformat Infrastruct Sweden, Solna, Sweden..
Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Genet, Istanbul, Turkiye..
Show others and affiliations
2025 (English)In: Nature Communications, E-ISSN 2041-1723, Vol. 16, no 1, article id 7130Article in journal (Refereed) Published
Abstract [en]

The ability to analyze whether DNA contains lesions is essential in identifying mutagenic substances. Currently, the detection of single-stranded DNA breaks (SSBs) lacks precision. To address this limitation, we develop a method for sequence-templated erroneous end-labelling sequencing (STEEL-seq), which enables the mapping of SSBs. The method requires a highly error-prone DNA polymerase, so we engineer a chimeric DNA polymerase, Sloppymerase, capable of replicating DNA in the absence of one nucleotide. Following the omission of a specific nucleotide (e.g., dATP) from the reaction mixture, Sloppymerase introduces mismatches directly downstream of SSBs at positions where deoxyadenosine should occur. This mismatch pattern, coupled with the retention of sequence information flanking these sites, ensures that the identified hits are bona fide SSBs. STEEL-seq is compatible with a variety of sequencing technologies, as demonstrated using Sanger, Illumina, PacBio, and Nanopore systems. Using STEEL-seq, we determine the SSB/base pair frequency in the human genome to range between 0.7 and 3.8 x 10-6 with an enrichment in active promoter regions.

Place, publisher, year, edition, pages
Springer Nature, 2025. Vol. 16, no 1, article id 7130
National Category
Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-565592DOI: 10.1038/s41467-025-62512-4ISI: 001548574700015PubMedID: 40759655Scopus ID: 2-s2.0-105012487075OAI: oai:DiVA.org:uu-565592DiVA, id: diva2:1993970
Funder
Swedish Cancer Society, 22 2306 PjSwedish Research CouncilKnut and Alice Wallenberg Foundation, KAW 2020.0239Knut and Alice Wallenberg Foundation, KAW 2017.0003Available from: 2025-09-01 Created: 2025-09-01 Last updated: 2025-10-21Bibliographically approved
In thesis
1. Utilising DNA Modifying Enzymes for Method Development in Molecular Biology
Open this publication in new window or tab >>Utilising DNA Modifying Enzymes for Method Development in Molecular Biology
2025 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Method development plays a critical role in advancing molecular biology by enabling the detection, visualization, and interpretation of complex cellular processes. This dissertation focused on the development and optimization of methods based on DNA modifying enzymes to investigate DNA damage and protein–protein interactions—key mechanisms in genomic integrity, stress response, and gene regulation.

The first part of the work involved the development of Polymerase-Assisted DNA Damage Analysis (PADDA), a method combining the comet assay with enzymatic labelling to distinctively detect DNA single-strand breaks (SSBs) and double-strand breaks (DSBs) with fluorescence microscopy.

For a genome-wide detection of SSBs, a novel sequencing-based method—Sequence-Templated Erroneous End-Labelling sequencing (STEEL-seq) was developed. The method is based on an engineered, artificial DNA polymerase, Sloppymerase. Its highly error-prone activity allows for DNA synthesis in absence of a specific nucleotide (e.g. dATP), creating unique patterns of mismatches directly downstream of an SSB. These mismatches can be detected after DNA sequencing analysis and give information about bona fide SSBs. The method was validated using multiple sequencing platforms, revealing enrichment of SSBs at promoter regions of actively transcribed genes.

The final part of the work covers a new antibody-based proximity assay for the detection of endogenous protein-protein interactions - Enzyme-Activated Proximity of Oligonucleotides Sensing (EPOS). Across multiple cellular models, EPOS could produce robust results for the detection of PPIs with higher resolution, improved dynamic range and increased sensitivity compared with in situ proximity ligation assay.

Collectively, the methods developed during this project demonstrate the transformative potential of enzymatic tools in molecular biology. By enabling more precise and accessible analysis of DNA damage and protein interactions, these approaches provide valuable platforms for future research in genomics, cell biology, and biomedical science.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2025. p. 60
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 1651-6192 ; 388
Keywords
Method development, molecular biology, DNA damage, protein-protein interactions
National Category
Pharmaceutical Sciences
Research subject
Molecular Life Sciences
Identifiers
urn:nbn:se:uu:diva-570057 (URN)978-91-513-2645-0 (ISBN)
Public defence
2025-12-11, B22, BMC, Husargatan 3, Uppsala, 09:00 (English)
Opponent
Supervisors
Available from: 2025-11-18 Created: 2025-10-21 Last updated: 2025-11-18

Open Access in DiVA

fulltext(3536 kB)676 downloads
File information
File name FULLTEXT01.pdfFile size 3536 kBChecksum SHA-512
562fff0ba7608757bd6d9a512e20289ff3622932c8682096ecd7bd405e942375659e7c5efe12133d931a33a7c17ef03340b2111b2a3f50f2186abbfcd3a20245
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Wenson, LeonieHeldin, JohanSundqvist, AndersSchaal, WesleySandbaumhüter, Friederike A.Jansson, Erik T.Chen, XingqiStenerlöw, BoEspinoza, Jaime A.Lennartsson, JohanSpjuth, OlaSöderberg, Ola

Search in DiVA

By author/editor
Wenson, LeonieHeldin, JohanSundqvist, AndersSchaal, WesleySandbaumhüter, Friederike A.Jansson, Erik T.Chen, XingqiStenerlöw, BoEspinoza, Jaime A.Lennartsson, JohanSpjuth, OlaSöderberg, Ola
By organisation
Department of Pharmaceutical BiosciencesScience for Life Laboratory, SciLifeLabMolecular Tools and Functional GenomicsDepartment of Immunology, Genetics and PathologyCancer precision medicine
In the same journal
Nature Communications
Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 677 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 641 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf